Free Cash Flow

Teva's new Eylea biosimilar hits Europe, a key move in its 'Pivot to Growth' strategy that promises to shake up the lucrative ophthalmology market.

As AI tools offer students instant answers, EdTech firm Thea has served a billion questions instead. We investigate its 'Socratic' model and its ambitious bid to rewire learning.

CrowdStrike reports record earnings and a stock split, but its true story lies in deep AI pacts with OpenAI. Is it enough to secure the AI frontier?

Farmer Mac's latest preferred stock dividend underscores its financial health, reassuring income investors while fueling its mission to fund rural broadband and renewable energy.

Fairplay's new user verification signals a market-wide shift. As India's stringent new rules take hold, compliance is becoming a key strategic asset.

AM Best affirms Fairfax's 'Excellent' rating after a year of record profits and major catastrophes. We deconstruct the strategy behind this financial paradox.

As The Conference Board honors S&P Global and UL Solutions, it’s clear that investing in people is no longer a soft skill—it's the core of modern strategy.

Stonegate Capital's updated coverage validates AB Science's pivot to ALS and AML, but can its promising clinical assets and shrewd financing de-risk the path forward?

QuadReal's appointment of Deloitte veteran Trevor Nakka signals a strategic pivot, adding elite financial governance to its $98.5B portfolio to fuel a disciplined global expansion.

Shake Shack's lowered guidance reveals a consumer trading down from premium burgers, a worrying sign for the entire fast-casual industry's health.

Penn Highlands Healthcare is offering up to $65K in loan repayment to build its workforce. Is this the new blueprint for solving talent shortages?

Aethlon Medical's upcoming financial report is more than a balance sheet; it's a test of viability for its revolutionary Hemopurifier blood filter.

Amid global conflict and soaring oil prices, Calgary's Surge Energy is turning market volatility into shareholder value by accelerating drilling and capital returns.

Facing a severe cash crunch, Jasper Therapeutics is exploring a sale or even a shutdown, placing the future of its promising urticaria drug, briquilimab, in limbo.

IREN and BE Networks are building a massive 50,000-GPU AI factory in a virtual world first, using NVIDIA's digital twin tech to ensure perfection before deployment.

Discover how PURE Insurance's unique reciprocal model is paying its high-net-worth members, turning policyholders into direct financial beneficiaries.

A new industry survey reveals that AI workloads are causing observability costs to skyrocket, creating a crisis of trust and visibility for tech teams.

A top financial forum is urging a GST hike, corporate tax cuts, and a radical revamp of retirement savings in its bold 2026 federal budget proposal.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

EastGroup Properties announced its 186th straight dividend, a testament to its financial stability and the enduring resilience of industrial real estate.